While at first glance this suggests that the induction of HO-1 may not be a valuable therapeutic in a bacterial disease, the inability of neutrophils to kill Mtb in the context of neutrophil-mediated immunopathology suggest that neutrophil targeted immunosuppression may be beneficial in TB. This evidence concerns the gene HMOX1 and tuberculosis.